Amicus’ Pombiliti and Opfolda received approval from the UK MHRA through the Inn...
The Phase IIb trial in idiopathic pulmonary fibrosis for GB0139 did not meet its...
Illumina has faced a series of legal challenges to its 2021 acquisition of Grail...
AGC has entered into an agreement with Asahi Kasei to produce clinical drug subs...
Precision BioSciences and Imugene have concluded a strategic transaction for wor...
Explore Capmatic's advanced solutions in solid dosage packaging, tailor-made for...
Paradoxically, medicines under the U.S. drug-pricing system are both too cheap a...
The Senate might hold up the nomination of Monica Bertagnolli for NIH director f...
Not-for-profit CommonSpirit Health paid its former CEO, Lloyd Dean, $35.5 millio...
Experts say a mishmash of ways more than 3,000 counties calculate heat deaths me...
Researchers found strong correlation between fine particulates from wildfire smo...
The family of Henrietta Lacks, whose “immortal cell line” has led to medical inn...
Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief amo...
An experimental drug for FOP symbolizes a future in which years of research, adv...
Just weeks after UnitedHealth's Optum posted its lowest profit margin in a decad...
Once seen as a way to innovate, many hospitals are now dialing back on venture c...
